ESCRS - Mysterious maculopathy case study ;
ESCRS - Mysterious maculopathy case study ;

Mysterious maculopathy case study

Diagnosis in this true mystery evaded everyone in attendance

Mysterious maculopathy case study
Leigh Spielberg
Leigh Spielberg
Published: Tuesday, September 12, 2017
[caption id="attachment_9441" align="alignright" width="1024"] Laura Kuehlewein[/caption] Dr Laura Kuehlewein, University Clinic Tübingen, Germany, presented a particularly challenging case during the Mystery Cases session of the first Young Retinal Specialists (YOURS) Day on Friday at the 17th Annual EURETINA conference. It’s fair to say that her case, entitled “Mysterious Maculopathy”, provided the audience with a true mystery, the diagnosis of which evaded everyone in attendance. It concerned a 54-year-old female with long-standing, bilaterally decreased visual acuity (20/200 in both eyes). She presented due to flicker scotomas upon awakening for the previous two months. She was hyperopic (+2.25) and had distorted pupils ODS. Fundus examination revealed extensive lesions resembling hard exudates, OS>OD, but there was no diabetes or arterial hypertension. There was hypoautofluorescence centrally and along the arcades ODS, and flourescein angiography showed early-phase, well demarcated hyperfluorescent lesions that did not increase in size in the later phases. The optic discs were normal. OCT displayed outer retinal atrophy ODS, with retinal pigment epithelial detachments, both large and small, OS>OD. Further questioning revealed similar symptoms in her sister. Genetic testing revealed a homozygotic BEST1 mutation. This led to the diagnosis of autosomal recessive bestrophinopathy. There was a silence in the auditorium, which likely made everyone feel better that no one else had thought of this diagnosis. After all, fewer than 20 such cases have been described worldwide. After a moment or two, a delegate stood up and asked, “How much time passed between initial presentation and final diagnosis?” “Years,” answered Dr Kuehlewein.
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;